Peng Ejun, Xia Ding, Gao Wenxi, Zhan Ying, Yang Huan, Yang Xiaoqi, Xu Hua, Qu Xiaoling, Sun Jie, Wang Shaogang, Ye Zhangqun, Tang Kun, Chen Zhiqiang
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Urology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China.
Eur Urol Open Sci. 2020 Jul;20:20-27. doi: 10.1016/j.euros.2020.07.004. Epub 2020 Jul 30.
Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic.
We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients.
This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and May 11, 2020 from two tertiary hospitals in Wuhan, China.
Chest computed tomography (CT) images, nucleic acid tests (NATs), and serum antibody were examined at the outpatient department and 1 wk after admission for all patients.
The chest CT images, NATs, serum antibody results, and clinical data were collected and analyzed.
None of the 319 patients was found to be SARS-CoV-2 NAT positive. Ten and four patients were detected to be immunoglobulin (Ig)G and IgM positive, respectively. The chest CT features of 116 patients showed abnormal lung findings. During the 1-wk isolation, one patient initially being IgG positive only was found to be IgM positive, and another initially IgM-positive patient had a rising IgG level. Through risk assessment, we identified seven patients with very high and high risk for hospital transmission, and delayed the surgery while maintaining close follow-up. Five intermediate-risk patients were operated on successfully under paravertebral block or epidural anesthesia to avoid opening the airway with endotracheal intubation. The remaining 104 low-risk and 203 normal patients underwent normal surgery.
Of the 319 patients, seven were identified as very high and high risk, which reinforced the importance of epidemic surveillance of discharged COVID-19 patients and asymptomatic infections. Five intermediate-risk patients were operated on successfully under regional anesthesia.
Our experience of risk assessment and management practice may provide a strategy to prevent severe acute respiratory syndrome coronavirus 2 transmission to hospitalized urological patients after the coronavirus disease 2019 (COVID-19) pandemic.
检测到新出现的无症状严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染,且发现多例患者再次出现SARS-CoV-2阳性,这为2019冠状病毒病(COVID-19)大流行后住院的患者敲响了警钟。
我们调查了SARS-CoV-2在住院泌尿外科患者中发生医院内传播的风险及预防措施。
设计、场所和参与者:这是一项对2020年4月20日至2020年5月11日期间在中国武汉两家三级医院收治的319例住院泌尿外科患者进行的回顾性研究。
对所有患者在门诊及入院1周后进行胸部计算机断层扫描(CT)检查、核酸检测(NAT)及血清抗体检测。
收集并分析胸部CT图像、NAT、血清抗体结果及临床数据。
319例患者中未发现SARS-CoV-2核酸检测阳性。分别有10例和四例患者检测到免疫球蛋白(Ig)G和IgM阳性。116例患者的胸部CT特征显示肺部有异常表现。在为期1周的隔离期间,一名最初仅IgG阳性的患者被发现IgM阳性,另一名最初IgM阳性的患者IgG水平升高。通过风险评估,我们确定了7例医院内传播风险极高和高的患者,推迟了手术并密切随访。5例中度风险患者在椎旁阻滞或硬膜外麻醉下成功进行了手术,以避免气管插管开放气道。其余104例低风险和203例正常风险患者接受了常规手术。
在319例患者中,7例被确定为风险极高和高,这凸显了对COVID-19出院患者及无症状感染者进行疫情监测的重要性。5例中度风险患者在区域麻醉下成功进行了手术。
我们的风险评估和管理实践经验可能为预防2019冠状病毒病(COVID-19)大流行后SARS-CoV-2传播至住院泌尿外科患者提供一种策略。